Neurocrine Biosciences (NBIX) Operating Margin (2009 - 2026)
Neurocrine Biosciences' Operating Margin was 29.51% in Q3 2026, down 0.56 percentage points from 30.07% a year earlier but up 13.71 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Operating Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neurocrine Biosciences' Operating Margin was 23.96% through Sep 30, 2026, up 3.46 percentage points year-over-year; for FY2025, it was 21.64%, down 2.58 percentage points from FY2024.
- Operating Margin shows a five-year change of +6.06 percentage points (FY2020 to FY2025).
- In earlier years, Operating Margin was 24.22% in FY2024 (+10.93 pp), 13.30% in FY2023 (-3.43 pp), 16.73% in FY2022 (+7.68 pp) and 9.04% in FY2021 (-6.54 pp).
- Quarterly Operating Margin has moved between -27.16% (Q1 2023) and 30.07% (Q3 2025) over five years.
- Compared with a year earlier, Operating Margin was higher in three of the last eight quarters, with an average year-over-year change of -0.92 percentage points.
- The best year-over-year quarter for Operating Margin over five years was Q1 2024 (a gain of 46.43 percentage points); the worst was Q4 2021 (a drop of 40.60 percentage points).
- Per Business Quant data, NBIX's Operating Margin in the three quarters before Q3 2026 was 15.80% (Q2 2026), 23.74% (Q1 2026) and 26.18% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 29.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 29.51% |
| Jun 30, 2026 | 15.80% |
| Mar 31, 2026 | 23.74% |
| Dec 31, 2025 | 26.18% |
| Sep 30, 2025 | 30.07% |
| Jun 30, 2025 | 21.18% |
| Mar 31, 2025 | 4.12% |
| Dec 31, 2024 | 22.62% |
| Sep 30, 2024 | 29.55% |
| Jun 30, 2024 | 24.64% |
| Mar 31, 2024 | 19.27% |
| Dec 31, 2023 | 29.17% |
| Sep 30, 2023 | 28.31% |
| Jun 30, 2023 | 16.26% |
| Mar 31, 2023 | -27.16% |
| Dec 31, 2022 | 25.10% |
| Sep 30, 2022 | 22.63% |
| Jun 30, 2022 | 14.46% |
| Mar 31, 2022 | 1.00% |
| Dec 31, 2021 | -11.63% |
API Access
Neurocrine Biosciences Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();